Joseph Henson
University of Leicester
102 Papers
163 Citations
Joseph Henson is an academic researcher from University of Leicester. The author has contributed to research in topics: Medicine & Type 2 diabetes. The author has an hindex of 22, co-authored 65 publications. Previous affiliations of Joseph Henson include Loughborough University & Leicester General Hospital.
Chat about Author
Papers
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health.
Joseph Henson,Joseph Henson,Thomas Yates,Stuart J. H. Biddle,Charlotte L. Edwardson,Charlotte L. Edwardson,Kamlesh Khunti,Emma G. Wilmot,Laura J. Gray,Trish Gorely,Myra A. Nimmo,Melanie J. Davies +11 more
TL;DR: In adults at high risk of type 2 diabetes mellitus, time spent sedentary is strongly and adversely associated with cardiometabolic health and may be a more important indicator of poor health than MVPA.
Sedentary time and markers of chronic low-grade inflammation in a high risk population.
Joseph Henson,Joseph Henson,Thomas Yates,Thomas Yates,Charlotte L. Edwardson,Charlotte L. Edwardson,Kamlesh Khunti,Kamlesh Khunti,Duncan Talbot,Laura J. Gray,Thomas M. Leigh,Patrice Carter,Patrice Carter,Melanie J. Davies,Melanie J. Davies +14 more
TL;DR: Novel findings from a high risk population recruited through primary care suggest that sedentary behaviour may influence markers associated with inflammation, independent of MVPA, glycaemia and adiposity.
Sedentary behaviour as a new behavioural target in the prevention and treatment of type 2 diabetes.
Joseph Henson,Joseph Henson,David W. Dunstan,David W. Dunstan,Melanie J. Davies,Melanie J. Davies,Thomas Yates,Thomas Yates +7 more
TL;DR: Key definitions, issues and evidence underpinning the link between sedentary behaviour and chronic disease are highlighted in order to better inform clinicians and patients about the importance of incorporating reduced sitting time into type 2 diabetes mellitus management and prevention pathways.
111
A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans.
TL;DR: It is demonstrated that the loss of LBM and skeletal muscle associated with weight loss induced by GLP-1RAs and SGLT2is predominantly comprises a reduction in FM, although significant heterogeneity exists between studies.
Rationale and design of the ADDITION-Leicester study, a systematic screening programme and Randomised Controlled Trial of multi-factorial cardiovascular risk intervention in people with Type 2 Diabetes Mellitus detected by screening
Webb,Kamlesh Khunti,Balasubramanian Thiagarajan Srinivasan,Laura J. Gray,Nick Taub,Sandra Campbell,J. Barnett,Joseph Henson,S Hiles,Azhar Farooqi,Simon J. Griffin,Nicholas J. Wareham,Melanie J. Davies +12 more
TL;DR: A single-blind cluster randomised, parallel group trial among people with screen-detected T2DM comparing a protocol driven intensive multi-factorial treatment with conventional care and contributing significantly to the understanding of the health care needs of UK South Asians.